Answers are grounded in this paper and cite their sources.
Part research project, part commercial stimulus, this enormous sequencing programme could usher genomic medicine into mainstream use, Mark Peplow reports
No takes yet. Share an insight, caveat, or question.
Mark Peplow (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: